Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans
- PMID: 16080087
- DOI: 10.1086/432470
Multicenter clinical evaluation of the (1-->3) beta-D-glucan assay as an aid to diagnosis of fungal infections in humans
Abstract
Background: Measurement of (1-->3)-beta-D-Glucan (BG) has emerged as an adjunct diagnostic strategy for invasive fungal infections (IFI).
Methods: Subjects at 6 clinical sites in the United States were enrolled as either fungal infection-negative subjects (n = 170) or subjects with proven or probable IFI according to European Organization for the Research and Treatment of Cancer/Mycoses Study Group criteria (n = 163). A central laboratory and 4 sites performed assays. A single sample was obtained per patient and was evaluated using an assay to detect serum BG derived from fungal cell walls (range, 0 to > 7000 pg/mL).
Results: At a cutoff of 60 pg/mL, the sensitivity and specificity of the assay were 69.9% and 87.1%, respectively, with a positive predictive value (PPV) of 83.8% and a negative predictive value (NPV) of 75.1%. At a cutoff value of 80 pg/mL, the sensitivity and specificity were 64.4% and 92.4%, respectively, with a PPV of 89% and an NPV of 73%. Of the 107 patients with proven candidiasis, 81.3% had positive results at a cutoff value of 60 pg/mL, and 77.6% had positive results at a cutoff value of 80 pg/mL. Of the 10 patients with aspergillosis, 80% had positive results at cutoff values of 60 and 80 pg/mL. The 3 subjects diagnosed with Fusarium species had positive results at a cutoff value of 60 pg/mL. Patients infected with Mucor or Rhizopus species (both of which lack BG) had negative results at both cutoff values, and of the 12 patients with Cryptococcus infection, 3 had positive results at a cutoff value of 60 pg/mL, and 2 had positive results at a cutoff value of 80 pg/mL. Of the subjects with proven positive results who were receiving antifungal therapy (n = 118), 72.9% had results positive for BG at a cutoff value of 60 pg/mL, and 69.5% had results positive for BG at a cutoff value of 80 pg/mL. The interlaboratory sample test r2 was 0.93.
Conclusion: Reproducible assay results with high specificity and high PPV in a multicenter setting demonstrate that use of an assay to detect serum BG derived from fungal cell walls is a useful diagnostic adjunct for IFI.
Comment in
-
(1-->3) beta -D-glucan assay in the diagnosis of invasive fungal infections.Clin Infect Dis. 2006 Apr 1;42(7):1054-6; author reply 1056. doi: 10.1086/501130. Clin Infect Dis. 2006. PMID: 16511777 No abstract available.
Similar articles
-
[Detection of 1,3-beta-D glucan for diagnosis of invasive fungal infections in hematooncological patients: usefulness for screening of invasive mycosis and for confirmation of galactomannan positive results].Klin Mikrobiol Infekc Lek. 2009 Apr;15(2):48-57. Klin Mikrobiol Infekc Lek. 2009. PMID: 19488961 Czech.
-
The (1,3){beta}-D-glucan test as an aid to early diagnosis of invasive fungal infections following lung transplantation.J Clin Microbiol. 2010 Nov;48(11):4083-8. doi: 10.1128/JCM.01183-10. Epub 2010 Aug 18. J Clin Microbiol. 2010. PMID: 20720025 Free PMC article.
-
1,3-Beta-D-glucan antigenemia for early diagnosis of invasive fungal infections in neutropenic patients with acute leukemia.Clin Infect Dis. 2008 Mar 15;46(6):878-85. doi: 10.1086/527382. Clin Infect Dis. 2008. PMID: 18260755
-
β-Glucan antigenemia assay for the diagnosis of invasive fungal infections in patients with hematological malignancies: a systematic review and meta-analysis of cohort studies from the Third European Conference on Infections in Leukemia (ECIL-3).Clin Infect Dis. 2012 Mar 1;54(5):633-43. doi: 10.1093/cid/cir897. Epub 2011 Dec 23. Clin Infect Dis. 2012. PMID: 22198786 Review.
-
A systematic review and meta-analysis of diagnostic accuracy of serum 1,3-β-D-glucan for invasive fungal infection: Focus on cutoff levels.J Microbiol Immunol Infect. 2015 Aug;48(4):351-61. doi: 10.1016/j.jmii.2014.06.009. Epub 2014 Jul 28. J Microbiol Immunol Infect. 2015. PMID: 25081986 Review.
Cited by
-
Diagnosis of Invasive Fungal Diseases in Hematological Malignancies: A Critical Review of Evidence and Turkish Expert Opinion (TEO-2).Turk J Haematol. 2014 Dec 5;31(4):342-56. doi: 10.4274/tjh.2014.0218. Turk J Haematol. 2014. PMID: 25541650 Free PMC article.
-
Emerging fungal infections in solid organ transplant recipients.Infect Dis Clin North Am. 2013 Jun;27(2):305-16. doi: 10.1016/j.idc.2013.02.004. Epub 2013 Apr 17. Infect Dis Clin North Am. 2013. PMID: 23714342 Free PMC article. Review.
-
Usage of 1,3-β-D-Glucan for Early Detection of Invasive Mycoses and Outcome Parameter in Immunocompromised Critically Ill Patients.Mycopathologia. 2016 Dec;181(11-12):815-821. doi: 10.1007/s11046-016-0061-0. Epub 2016 Sep 12. Mycopathologia. 2016. PMID: 27619810
-
Fungal infections of the CNS: treatment strategies for the immunocompromised patient.CNS Drugs. 2007;21(4):293-318. doi: 10.2165/00023210-200721040-00004. CNS Drugs. 2007. PMID: 17381184 Review.
-
Invasive aspergillosis: epidemiology, diagnosis and management in immunocompromised patients.Drugs. 2007;67(11):1567-601. doi: 10.2165/00003495-200767110-00004. Drugs. 2007. PMID: 17661528 Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical